Prostate Cancer Diagnosis via Multi-b-value MRI Autoencoder Integration
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current diagnostic techniques for prostate cancer, such as digital rectal examination, PSA tests, and needle biopsies, are invasive, costly, and have low sensitivity and specificity, while existing CAD systems for prostate cancer diagnosis from MRI data are limited by inconsistent b-values and lack of integration with clinical biomarkers, necessitating improved methods for accurate and non-invasive detection.
Innovation Solution
A method and system that processes MRI prostate data at multiple b-values using autoencoders to generate imaging output probability data, combined with biological data through a data classifier, to create a comprehensive diagnosis, integrating imaging markers with clinical biomarkers for enhanced accuracy.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If multiple b-values are processed through separate autoencoders, then diagnostic accuracy is improved by reducing sensitivity to b-value selection, but system complexity increases
Solution Approach 1:
The patent divides the processing of multi-b-value MRI data into separate autoencoders, with each autoencoder dedicated to processing data from a specific b-value. This segmentation allows each component to specialize in handling the unique characteristics of its assigned b-value, improving overall diagnostic accuracy while maintaining manageable complexity through modular design
Solution Approach 2:
The patent combines the outputs from multiple separate autoencoders (each processing different b-values) into a unified diagnostic system. By merging the processed information from multiple sources, the system achieves reduced sensitivity to individual b-value selection and improved overall diagnostic accuracy
2Reliability
If imaging markers are integrated with clinical biomarkers, then diagnostic accuracy and reliability are improved, but device complexity and data processing requirements increase
Solution Approach 1:
The patent creates a composite diagnostic approach by integrating two distinct types of data: imaging markers from MRI scans and clinical biomarkers from patient records. This composite methodology combines the strengths of both data sources, achieving high diagnostic reliability and accuracy while systematically managing the complexity through structured integration
3Measurement precision
If deep learning autoencoders are used for feature extraction, then measurement precision and diagnostic accuracy are improved, but computational requirements and processing time increase
Solution Approach 1:
The patent employs deep learning autoencoders to perform preliminary feature extraction and data processing before the final diagnostic classification. By pre-processing the MRI data and extracting relevant features in advance, the system reduces the computational burden on subsequent processing stages while maintaining high measurement precision
Data Source
AI summary
Systems and methods for diagnosing prostate cancer. Image sets (e.g., MRI collected at one or more b-values) and biological values (e.g., prostate specific antigen (PSA)) have features extracted and integrated to produce a diagnosis of prostate cancer. The image sets are analyzed primarily in three steps: (1) segmentation, (2) feature extraction, smoothing, and normalization, and (3) classification. The biological values are analyzed primarily in two steps: (1) feature extraction and (2) classification. Each analysis results in diagnostic probabilities, which are then combined to pass through an additional classification stage. The end result is a more accurate diagnosis of prostate cancer.